Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome (IBS)
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate whether renzapride will help alleviate the
symptoms associated with constipation predominant irritable bowel syndrome in female
patients.